PetMed Express Dirección

Dirección controles de criterios 2/4

El CEO de PetMed Express' es Sandra Campos, nombrado en Apr 2024, tiene una permanencia de menos de un año. posee directamente un 0.008% de las acciones de la empresa, con un valor de €6.01K. La antigüedad media del equipo directivo y de la junta directiva es de 2.3 años y 4 años, respectivamente.

Información clave

Sandra Campos

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEO	n/a
Permanencia del CEO	less than a year
Participación del CEO	0.008%
Permanencia media de la dirección	2.3yrs
Promedio de permanencia en la Junta Directiva	4yrs

Actualizaciones recientes de la dirección

Recent updates

CEO

Sandra Campos (56 yo)

less than a year

Permanencia

Ms. Sandra Y. Campos is Independent Director of PetMed Express, Inc. from May 17, 2023 and serves as its CEO and President since April 29, 2024. She serves as an Independent Director at Commerce Fabric, In...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Christine Chambers	CFO, Principal Financial Officer	1.8yrs	US$651.48k	0.098% $ 73.4k
Mathew Hulett	Advisor	less than a year	US$534.12k	3.01% $ 2.3m
Sandra Campos	President	less than a year	sin datos	0.0080% $ 6.0k
Mark Moseley	Chief Technology & Information Officer	2.3yrs	sin datos	0.21% $ 155.0k
Daniel Pingree	Chief Marketing Officer	2.3yrs	sin datos	0.11% $ 81.2k
Jacqueline Smith	Vice President of People	2.3yrs	sin datos	0.048% $ 36.2k
Wendy Zalai	Corporate Controller & Corporate Secretary	3.3yrs	sin datos	sin datos

2.3yrs

Permanencia media

52yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de PQM se considera experimentado (2.3 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Sandra Campos	President	less than a year	sin datos	0.0080% $ 6.0k
Gian Fulgoni	Independent Director	21.5yrs	US$218.20k	0.54% $ 404.3k
Diana Purcel	Independent Director	2.1yrs	US$251.07k	0.046% $ 34.6k
Leslie C. Campbell	Independent Chairman of the Board	5.8yrs	US$203.20k	0.20% $ 147.7k

4.0yrs

Permanencia media

60.5yo

Promedio de edad

Junta con experiencia: La junta directiva de PQM se considera experimentada (3.9 años de antigüedad promedio).

PetMed Express Dirección

Dirección controles de criterios 2/4

Información clave

Actualizaciones recientes de la dirección

PetMed Express, Inc. Announces Executive Changes

PetMed Express, Inc. Announces Management Changes

Independent Chairman of the Board recently bought €281k worth of stock

CEO, President & Director recently bought €94k worth of stock

High number of new directors

PetMed Express, Inc., Annual General Meeting, Aug 03, 2023

Recent updates

PetMed Express, Inc. Announces Executive Changes

PetMed Express Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q

PetMed Express Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Report on Form 10-Q

PetMed Express, Inc. announced delayed 10-Q filing

PetMed Express, Inc. announced delayed 10-Q filing

PetMed Express, Inc. to Report Q3, 2024 Results on Feb 08, 2024

PetMed Express, Inc. Announces Management Changes

Independent Chairman of the Board recently bought €281k worth of stock

CEO, President & Director recently bought €94k worth of stock

Second quarter 2024 earnings released: US$0.003 loss per share (vs US$0.13 profit in 2Q 2023)

PetMed Express, Inc. Makes Decision to Suspend the Quarterly Dividend Effective the Quarter Ended September 30, 2023

PetMed Express, Inc. to Report Q2, 2024 Results on Oct 30, 2023

Now 21% undervalued after recent price drop

First quarter 2024 earnings released: US$0.044 loss per share (vs US$0.14 profit in 1Q 2023)

PetMed Express, Inc. to Report Q1, 2024 Results on Jul 31, 2023

Now 21% undervalued after recent price drop

High number of new directors

Full year 2023 earnings released: EPS: US$0.011 (vs US$1.05 in FY 2022)

PetMed Express, Inc. Declares a Quarterly Dividend, Payable on June 12, 2023

PetMed Express, Inc., Annual General Meeting, Aug 03, 2023

PetMed Express, Inc. Appoints Sandra Y. Campos to its Board of Directors

PetMed Express, Inc. to Report Q4, 2023 Results on May 22, 2023

Third quarter 2023 earnings released: US$0.001 loss per share (vs US$0.21 profit in 3Q 2022)

PetMed Express, Inc. Declares Quarterly Dividend, Payable on February 27, 2023

Investor sentiment improves as stock rises 17%

PetMed Express, Inc. to Report Q3, 2023 Results on Feb 06, 2023

PetMed Express, Inc. entered into an agreement to acquire PetCareRx, Inc. from Evolution VC Partners and Feenix Venture Partners.

PetMed Express, Inc. entered into an agreement to acquire PetCareRx, Inc. from Evolution VC Partners and Feenix Venture Partners.

Second quarter 2023 earnings released: EPS: US$0.13 (vs US$0.32 in 2Q 2022)

PetMed Express, Inc. Declares Quarterly Dividend, Payable on November 30, 2022

PetMed Express, Inc. to Report Q2, 2023 Results on Nov 07, 2022

Now 20% undervalued

Upcoming dividend of US$0.30 per share

First quarter 2023 earnings released: EPS: US$0.14 (vs US$0.22 in 1Q 2022)

Petmed Express, Inc. Declares Quarterly Dividend, Payable on August 19, 2022

PetMed Express, Inc. Announces Executive Changes

PetMed Express, Inc. to Report Q1, 2023 Results on Jul 25, 2022

PetMed Express, Inc., Annual General Meeting, Jul 28, 2022

PetMed Express, Inc., Annual General Meeting, Jul 28, 2022

Full year 2022 earnings released: EPS: US$1.05 (vs US$1.53 in FY 2021)

PetMed Express, Inc. Declares Quarterly Dividend, Payable on May 27, 2022

PetMed Express, Inc. to Report Q4, 2022 Results on May 09, 2022

PetMed Express, Inc. Appoints Diana Garvis Purcel to Board of Directors, Effective April 4, 2022

Upcoming dividend of US$0.30 per share

PetMed Express, Inc. Provides Sales Guidance for the Year 2022

Third quarter 2022 earnings: EPS in line with expectations, revenues disappoint

Second quarter 2022 earnings released: EPS US$0.32 (vs US$0.42 in 2Q 2021)

Independent Director Frank Formica has left the company

First quarter 2022 earnings released: EPS US$0.22 (vs US$0.39 in 1Q 2021)

Investor sentiment improved over the past week

Full year 2021 earnings released: EPS US$1.53 (vs US$1.29 in FY 2020)

Full year 2021 earnings released: EPS US$1.53 (vs US$1.29 in FY 2020)

PetMed Express, Inc. Declares a Quarterly Dividend, Payable on May 21, 2021

Independent Chairman Robert Schweitzer has left the company

PetMed Express, Inc. Announces Executive Changes

Corporate Secretary & General Counsel has left the company

Investor sentiment deteriorated over the past week

CFO & Treasurer recently sold €206k worth of stock

Third quarter 2021 earnings released: EPS US$0.38 (vs US$0.34 in 3Q 2020)

Revenue beats expectations

Revenue beats expectations

Revenue beats expectations

Revenue beats expectations

Third quarter 2021 earnings released: EPS US$0.38

New 90-day high: €28.65

PetMed Express, Inc. to Report Q3, 2021 Results on Jan 19, 2021

New 90-day high: €27.42

Second quarter 2021 earnings released: EPS US$0.42

Revenue misses expectations